Significant opportunities in emerging markets in Asia-Pacific and Latin America

Dublin, December 31, 2020 (GLOBE NEWSWIRE) – The “Research Antibodies and Reagents Market by Product {Antibodies [Type (Primary, Secondary), Production, Source, Research Area (Oncology, Neurology)], Reagents}, Technology (ELISA, Western Blot), Application, End User (Pharma, Academia) – Global Forecast to 2027. “The report was added to ResearchAndMarkets.com from offer.

The Antibodies and Research Reagents market is expected to grow at a CAGR of 5.6% from 2020 to 2027 to reach USD 6.32 billion by 2027.

Factors such as the growing demand for therapeutic proteins and personalized medicine, increased investments in stem cell research and the growing need for biomarker identification represent strong growth opportunities for players during the period. forecast. However, factors such as high cost and time associated with identifying and developing potential antibodies are expected to hamper the growth of this market.

In 2020, depending on the type, the antibody segment is expected to account for the largest share of this market. The large share of this segment is mainly attributed to the growing demand for antibodies for biomedical research, the growing focus on protein and cell research, and the growing number of biomarker discoveries.

On the basis of the technology, in 2020 the flow cytometry segment is poised to take the largest share of the antibody and research reagents market. Growing biomedical research for better diagnostics and therapies, increasing biomarker discovery initiatives, and growing cellular and molecular-based research are the factors driving this growth in this segment.

In 2020, the proteomics segment is expected to occupy the largest share of the antibody and research reagents market. The growing emphasis on protein-based research and the growing need for effective drugs using various protein-based disease profiles are the factors driving the growth of this segment.

The pharmaceutical and biotechnology industry widely adopts antibodies and research reagents for proteomics research and drug discovery and development.

An in-depth analysis of the geographic scenario of the Research Antibodies and Reagents Market provides detailed qualitative and quantitative insights for the major five geographies (North America, Europe, Asia-Pacific, Latin America & Middle East & Africa) as well as coverage of the main countries in each region. In 2020, North America is estimated to have the largest share of the antibody and research reagents market, followed by Europe, Asia-Pacific, Latin America, and the Middle East and of Africa.

Main topics covered:

1. Introduction
1.1. Market ecosystem
1.1.1. Market research for antibodies and reagents
1.1.2. Antibody and Reagent Market Research, by Product
1.2. Currency and limits
1.3. Key stakeholders

2. Research methodology
2.1. Research process
2.1.1. Secondary research
2.1.2. Primary research

3. Executive summary

4. Market overview
4.1. introduction
4.2. Market dynamics
4.2.1. Conductors
4.2.1.1. Increase in proteomics and genomics research studies
4.2.1.2. Increased funding for research activities
4.2.1.3. Growing collaboration between industry and universities
4.2.2. Detention
4.2.2.1. High cost and time associated with identifying and developing potential antibodies
4.2.3. Opportunities
4.2.3.1. Growing demand for therapeutic proteins and personalized drugs
4.2.3.2. Increased investment and focus on stem cell research
4.2.3.3. Growing need to identify new biomarkers
4.2.3.4. Significant opportunities in emerging markets in Asia-Pacific and Latin America
4.2.4. Challenges
4.2.4.1. Problems with the quality and stability of research antibodies
4.2.4.2. Intense pricing pressure on the main players

5. Market research for antibodies and reagents, by product
5.1. introduction
5.2. Antibody
5.2.1. Antibodies Market, By Type
5.2.1.1. Primary Antibodies
5.2.1.2. Secondary antibody
5.2.2. Antibodies Market, By Production Type
5.2.2.1. Monoclonal Antibody
5.2.2.2. Polyclonal antibody
5.2.2.3. Antibody fragments
5.2.3. Antibodies Market, By Source
5.2.3.1. Mouse
5.2.3.2. rabbit
5.2.3.3. Other sources
5.2.4. Antibody Market, by Research Area
5.2.4.1. Oncology
5.2.4.2. Infectious diseases
5.2.4.3. Heart disease
5.2.4.4. Immunology
5.2.4.5. Neurology
5.2.4.6. Stem cell research
5.2.4.7. Other areas of research
5.3. Reagents
5.3.1. Reagents for sample preparation
5.3.1.1. Media and serum
5.3.1.2. Dyes and dyes
5.3.1.3. Probes
5.3.1.4. Buffers
5.3.1.5. Solvents
5.3.2. Antibody production reagents
5.3.2.1. Enzymes
5.3.2.2. Protein
5.3.3. Other research reagents

6. Antibodies and Reagents Market Research, by Technology
6.1. introduction
6.2. Flow cytometry
6.3. Immunofluorescence
6.4. Immuno-enzymatic assay
6.5. Immunoprecipitation (IP)
6.6. Multiplex immunosorbent assay
6.7. Immunohistochemistry
6.8. Western blot
6.9. Other technologies

7. Antibodies and Reagents Market Research, By Application
7.1. introduction
7.2. Proteomics
7.3. Drug discovery and development
7.4. Genomics

8. Antibody and Reagent Market Research, by End User
8.1. introduction
8.2. Pharmaceutical and biotechnology industry
8.3. University and research institutes
8.4. Contract research organizations

9. Market research for antibodies and reagents, by geography

10. Competitive landscape
10.1. introduction
10.2. Key growth strategies
10.3. Competitive benchmarking
10.4. Market share analysis

11. Company profiles
11.1. Company overview
11.2. Financial overview
11.3. Product portfolio

• GE Healthcare (United States)
• Merck KGaA (Germany)
• Thermo Fisher Scientific Inc. (United States)
• F. Hoffmann La-Roche AG (Switzerland)
• Rockland Immunochemicals Inc. (United States)
• Johnson & Johnson (United States)
• Agilent Technologies Inc. (United States)
• Eli Lily and Company (United States)
• Becton Dickinson and Company (United States)
• Danaher Corporation (United States)
• PerkinElmer Inc. (United States)
• GenScript Biotech Corporation (United States)
• Lonza (Switzerland)
• Bio-Techne Corporation (United States)
• Bio-Rad Laboratories Inc. (POU)
• Teva Pharmaceutical Industries Limited (Israel)
• Santa Cruz Biotechnology Inc. (United States)
• BioLegend Inc. (United States)

For more information on this report, visit https://www.researchandmarkets.com/r/q5a7ww

Research and Markets also offers personalized research services providing targeted, comprehensive and personalized research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900